Charity Search / TOWER CANCER RESEARCH FOUNDATION
Medical Research (H00Z) IRS Verified DX Registered 990 on File

TOWER CANCER RESEARCH FOUNDATION

EIN: 95-4596354 · BEVERLY HILLS, CA 90211-2714 · United States · FY 2024 Data
3 out of 5 49 / 100 Based on 2+ years of filings
Financial strength (30%) 67/100
Reliability (20%) 55/100
Effectiveness (25%) 71/100
Impact (25%) No data yet
Financial data: FY 2024 · Scored 9/13/2026
Claim this Charity
CharityAI™ Score
Not yet evaluated
Mission Statement

Founded in 1996 by a group of dedicated physicians, patients, and volunteers, Tower Cancer Research Foundation has developed a legacy of supporting high impact research and clinical trials. This includes research that resulted in the approval of 15 new cancer drugs and the expansion of treatment options for cancer patients all over the world. To carry on this tradition, each year the non-profit awards a multitude of different scientific grants from one-year $100,000 Career Development Grants to five year $500,000 Senior Investigator Grants to $1,000,000 Multi-Disciplinary Discovery Funds.

Financial Overview — FY 2024
$3.1M
Total Revenue
$3.6M
Total Expenses
$1.2M
Net Assets
14
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio 69.0%
Fundraising Efficiency 535.1%
Operating Reserve 3.98x
Liability-to-Asset 62.8%
Revenue Diversification 116.1%
Executive Compensation $320K
Compared with Peers
FY 2024
Compared with 332 similar organizations (United States, Medical Research, $1M–$10M in expenses), FY 2024.
This organization Middle half of peers (P25–P75) Peer median
Ratio This org Peer median Position (P10 → P90)
Program expense ratio
Program expenses / total expenses · higher is better
69.0% 83.0%
P10P90
Bottom quarter
Admin expense ratio
Management and general / total expenses · lower is better
10.7% 10.7%
P10P90
Below median
Fundraising expense ratio
Fundraising expenses / total expenses · lower is better
20.3% 2.0%
P10P90
Bottom quarter
Fundraising efficiency
Fundraising expenses / gross fundraising income · lower is better
535.1% 97.3%
P10P90
Bottom quarter
Operating reserve
Months of expenses covered by net assets · higher is better
4.0 mo 12.8 mo
P10P90
Bottom quarter
Liabilities to assets
Total liabilities / total assets · lower is better
62.8% 10.1%
P10P90
Bottom quarter
Revenue concentration
Share of revenue from the largest source · lower is better
116.1% 90.7%
P10P90
Bottom quarter
Revenue growth
Year over year revenue growth
23.9% 12.5%
P10P90
Expense growth
Year over year expense growth
14.6% 11.1%
P10P90
Surplus margin
Surplus as a share of revenue
-15.6% 2.9%
P10P90
Financial History
Year Revenue Expenses Net Assets Program % Staff
2024 $3.1M $3.6M $1.2M 69.0% 14
2023 $2.5M $3.2M $1.4M 70.2% 15
2022 $2.9M $3.2M $1.7M 70.8% 16
2021 $6.3M $3.5M N/A 16
Donor Reviews
Write a Review
No reviews yet

Be the first to share your experience with this organization.


Write a Review
Minimum 20 characters
Reviews appear after moderation (usually within 24 hours)
Organization Details
EIN
95-4596354
State
CA
City
BEVERLY HILLS
ZIP
90211-2714
Classification
H00Z
Category
Medical Research
Rating
3★
Coverage
A
Last Updated
Aug 2026
IRS Ruling Year
1996
Foundation Code
15
Form 990
On File
Is this your organization?

Claim it to manage this profile, add your board, financials and impact metrics, and lift your CharityAI™ rating.

Claim this Charity
Back to Search New Search